Question · asked by 1 review
Summary of findings table ‐ Antipsychotic dose reduction vs dose continuation: Quality of life ‐ mean change/endpoint all available scales (combined scales and time points)
- Population
- patients with schizophrenia
- Intervention
- Summary of findings table ‐ Antipsychotic dose reduction
- Comparison
- dose continuation
- Outcome
- Quality of life ‐ mean change/endpoint all available scales (combined scales and time points)
What each review found
Include earlier review versions| Finding | Effect | Studies | GRADE certainty |
|---|---|---|---|
Summary of findings table ‐ Antipsychotic dose reduction vs dose continuation Quality of life ‐ mean change/endpoint all available scales (combined scales and time points) · people with schizophrenia Antipsychotic dose reduction compared to dose continuation for people with schizophrenia (2022) · Cochrane Headline outcomes only | no estimate extracted | 6 studies · 719 participants | Moderate |
Findings are shown side by side, never pooled across reviews.
The reviews
| Review | Searched up to | Included studies | AMSTAR 2 |
|---|---|---|---|
| Antipsychotic dose reduction compared to dose continuation for people with schizophrenia 2022 · Cochrane Headline outcomes only | Not reported | Not extracted | Not assessed |
How reviews are matched to this question
Reviews word the same question differently. Four decision models (TypeSafe's Jev, Liquid AI's d1-ultra, SubQ Snap and Baseten's Elephant) judged each wording of the population, intervention, comparator and outcome against the others; two wordings count as the same when at least three of them agree and none clearly disagrees, and findings count as this question only when all four elements match. Timing, setting and subgroup never split a question: they are shown on each finding.